News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
184 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (7)
2 (15)
3 (243)
4 (292)
5 (235)
6 (83)
7 (4)
8 (20)
9 (229)
10 (249)
11 (163)
12 (210)
13 (72)
14 (2)
15 (29)
16 (196)
17 (228)
18 (224)
19 (189)
20 (95)
21 (7)
22 (4)
23 (193)
24 (210)
25 (262)
26 (241)
27 (78)
28 (20)
29 (55)
30 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Biotech Beach
AVITA Medical Announces Listing on Nasdaq
Trading of American Depository Shares to begin under the ticker symbol “RCEL” on October 1st
September 30, 2019
·
5 min read
Drug Development
Debiopharm’s Novel IAP Antagonist Debio 1143 Achieves Outstanding Phase II Results for High-Risk Head and Neck Cancer Patients
Late breaking abstract results presented today at ESMO with chemo-radio sensitizer Debio 1143 present a promising breakthrough strategy to improve the front-line treatment of H&N cancer patients
September 30, 2019
·
4 min read
FDA
FDA Approves New Drug to Treat Diabetes-Related Kidney Disease
The National Kidney Foundation Statement about INVOKANA® (Canagliflozin)
September 30, 2019
·
2 min read
Pharm Country
AscellaHealth Named to “Soaring 76” List of Fastest-Growing Companies by the Philadelphia Business Journal
Innovative specialty pharmacy manager earns 14th spot on coveted 2019 list
September 30, 2019
·
2 min read
Previous
19 of 19